Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and transforming growth factor beta

3,4-dihydroxyphenylacetic acid has been researched along with transforming growth factor beta in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blunt, SB; Hötten, G; Opacka-Juffry, J; Pohl, J; Sullivan, AM1
Blunt, SB; Opacka-Juffry, J; Pohl, J; Sullivan, AM1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and transforming growth factor beta

ArticleYear
Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease.
    Neuroscience letters, 1997, Sep-19, Volume: 233, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bone Morphogenetic Proteins; Corpus Striatum; Dopamine; Growth Differentiation Factor 5; Growth Substances; Homovanillic Acid; Injections, Intraventricular; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Recombinant Proteins; Substantia Nigra; Transforming Growth Factor beta

1997
Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration.
    Brain research, 1999, Feb-06, Volume: 818, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bone Morphogenetic Proteins; Dopamine; Growth Differentiation Factor 5; Growth Substances; Humans; Injections, Intraventricular; Microinjections; Neuroprotective Agents; Rats; Recombinant Proteins; Rotation; Substantia Nigra; Transforming Growth Factor beta; Tyrosine 3-Monooxygenase

1999